Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study

BACKGROUND: Survival for pancreatic ductal adenocarcinoma is low, the role of adjuvant therapy remains controversial, and recent data suggest adjuvant chemoradiation (CRT) may decrease survival compared with surgery alone. Our goal was to examine efficacy of adjuvant CRT in resected pancreatic adeno...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hsu, Charles C., Herman, Joseph M., Corsini, Michele M., Winter, Jordan M., Callister, Matthew D., Haddock, Michael G., Cameron, John L., Pawlik, Timothy M., Schulick, Richard D., Wolfgang, Christopher L., Laheru, Daniel A., Farnell, Michael B., Swartz, Michael J., Gunderson, Leonard L., Miller, Robert C.
Format: Artigo
Langue:Inglês
Publié: Springer-Verlag 2010
Sujets:
Pancreatic Tumors
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840672/
https://ncbi.nlm.nih.gov/pubmed/20087786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-009-0743-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires